Pharma Equity Group A/S 2025 Annual Report
Company: Pharma Equity Group A/S
Sector: Finance & insurance
Country: Denmark
Year: 2025
Type: Annual Report
Pages: 63
The report describes 2025 as a year of strengthened governance and focused execution, including an updated investment strategy spanning Pharma and Medical Devices and the establishment of an Investment Committee. Reponex advanced RNX-011 toward a pivotal Phase 2 study and progressed RNX-051 development, while the Group reported zero revenue and a reduced loss before tax. CSR is presented as integrated into governance and decision-making, with patient outcomes, quality and safety, ethical conduct, human rights, environmental responsibility and anti-corruption highlighted.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.